Homer L. Pearce, Ph.D.

Dr. Homer Pearce served for 27-years at Eli Lilly devoting his research to cancer drug discovery and clinical development.  Dr. Pearce held several positions of increasing responsibility at Lilly, all of which were directed at the discovery and development of new drugs to treat cancer. He served as Vice President of Cancer Research and Clinical Investigation and became a Distinguished Research Fellow, Cancer Research. During this time Lilly’s cancer drug discovery group introduced 25 investigational drugs into clinical trials and 3 new drugs were approved for the treatment of cancer by worldwide regulatory agencies including Gemzar and ALIMTA. Dr. Pearce has since retired from Lilly, and has served in several board, consulting and advisory roles in the academic, government and biopharmaceutical communities.

Homer Pearce received a BS degree in chemistry from Texas A&M University in 1974 and was awarded a PhD in organic chemistry from Harvard University in 1979.